SARS-CoV-2-IN-109
SARS-CoV-2-IN-109 (compound 50) is a small molecule inhibitor that disrupts the SARS-CoV-2 Spike RBD-ACE2 interaction, blocking viral entry into VeroE6 cells with an EC50 of 26.5 μM. It exhibits in vivo anti-infection activity and has a favorable cytotoxicity profile (CC50 >100 μM), supporting its use in virology and antiviral drug discovery research.
Product Specifications
Field of Research
Infectious Disease & Virology
Molecular Formula
C34H26N2O2
Molecular Weight
494.58
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog